BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26586358)

  • 1. Anticoagulation with apixaban in a patient with a left ventricular assist device and gastrointestinal bleeding: A viable alternative to warfarin?
    Pollari F; Fischlein T; Fittkau M; Santarpino G
    J Thorac Cardiovasc Surg; 2016 Apr; 151(4):e79-81. PubMed ID: 26586358
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of new anticoagulant drugs in ventricular assist devices: Another brick in the wall?
    Miceli A; Glauber M
    J Thorac Cardiovasc Surg; 2016 Apr; 151(4):e83-4. PubMed ID: 26846871
    [No Abstract]   [Full Text] [Related]  

  • 3. Octreotide for recurrent intestinal bleeding due to ventricular assist device.
    Coutance G; Saplacan V; Belin A; Repessé Y; Buklas D; Massetti M
    Asian Cardiovasc Thorac Ann; 2014 Mar; 22(3):350-2. PubMed ID: 24585917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased incidence of angiodysplasia of the gastrointestinal tract and bleeding in patients with continuous flow left ventricular assist devices (LVADs).
    Muthiah K; Robson D; Macdonald PS; Keogh AM; Kotlyar E; Granger E; Dhital K; Spratt P; Hayward CS
    Int J Artif Organs; 2013 Jul; 36(7):449-54. PubMed ID: 23897227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and In Vitro Evidence That Left Ventricular Assist Device-Induced von Willebrand Factor Degradation Alters Angiogenesis.
    Bartoli CR; Zhang DM; Hennessy-Strahs S; Kang J; Restle DJ; Bermudez C; Atluri P; Acker MA
    Circ Heart Fail; 2018 Sep; 11(9):e004638. PubMed ID: 30354363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apixaban (Eliquis) in deep vein thrombosis and pulmonary embolism. Warfarin remains the standard therapy.
    Prescrire Int; 2015 Sep; 24(163):206. PubMed ID: 26417627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digoxin Is Associated With a Decreased Incidence of Angiodysplasia-Related Gastrointestinal Bleeding in Patients With Continuous-Flow Left Ventricular Assist Devices.
    Vukelic S; Vlismas PP; Patel SR; Xue X; Shitole SG; Saeed O; Sims DB; Chinnadurai T; Shin JJ; Forest SJ; Goldstein DJ; Jorde UP
    Circ Heart Fail; 2018 Aug; 11(8):e004899. PubMed ID: 30354557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occult gastrointestinal bleeding in patients with a left ventricular assist device axial flow pump: diagnostic tools and therapeutic algorithm.
    Tarzia V; Dal Lin C; Bottio T; Benvenuti S; Chilovi F; Gerosa G
    J Thorac Cardiovasc Surg; 2012 Apr; 143(4):e28-31. PubMed ID: 22306228
    [No Abstract]   [Full Text] [Related]  

  • 9. Video capsule endoscopy in left ventricular assist device recipients with obscure gastrointestinal bleeding.
    Amornsawadwattana S; Nassif M; Raymer D; LaRue S; Chen CH
    World J Gastroenterol; 2016 May; 22(18):4559-66. PubMed ID: 27182165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleeding with the artificial heart: Gastrointestinal hemorrhage in CF-LVAD patients.
    Gurvits GE; Fradkov E
    World J Gastroenterol; 2017 Jun; 23(22):3945-3953. PubMed ID: 28652649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial.
    Garcia DA; Wallentin L; Lopes RD; Thomas L; Alexander JH; Hylek EM; Ansell J; Hanna M; Lanas F; Flaker G; Commerford P; Xavier D; Vinereanu D; Yang H; Granger CB
    Am Heart J; 2013 Sep; 166(3):549-58. PubMed ID: 24016506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical problem-solving. A not-so-obscure cause of gastrointestinal bleeding.
    Brock AS; Cook JL; Ranney N; Rockey DC
    N Engl J Med; 2015 Feb; 372(6):556-61. PubMed ID: 25651250
    [No Abstract]   [Full Text] [Related]  

  • 13. Multicenter Evaluation of Octreotide as Secondary Prophylaxis in Patients With Left Ventricular Assist Devices and Gastrointestinal Bleeding.
    Shah KB; Gunda S; Emani S; Kanwar MK; Uriel N; Colombo PC; Uber PA; Sears ML; Chuang J; Farrar DJ; Brophy DF; Smallfield GB
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29141860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of discontinuation of anti-coagulation in patients with continuous-flow left ventricular assist devices.
    Kamdar F; Eckman P; John R
    J Heart Lung Transplant; 2014 Mar; 33(3):316-8. PubMed ID: 24462558
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of long-term anticoagulation in patients with a continuous-flow left-ventricular assist device: a pilot study.
    Jennings D; McDonnell J; Schillig J
    J Thorac Cardiovasc Surg; 2011 Jul; 142(1):e1-2. PubMed ID: 21529846
    [No Abstract]   [Full Text] [Related]  

  • 16. Apixaban for the Treatment of Japanese Subjects With Acute Venous Thromboembolism (AMPLIFY-J Study).
    Nakamura M; Nishikawa M; Komuro I; Kitajima I; Uetsuka Y; Yamagami T; Minamiguchi H; Yoshimatsu R; Tanabe K; Matsuoka N; Kanmuri K; Ogawa H
    Circ J; 2015; 79(6):1230-6. PubMed ID: 25912695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localizing an occult gastrointestinal bleeding by wireless PillCam SB capsule videoendoscopy in a patient with the HeartMate II left ventricular assist device.
    Bechtel JF; Wellhöner P; Charitos EI; Bucsky B; Morshuis M; Sievers HH
    J Thorac Cardiovasc Surg; 2010 Apr; 139(4):e73-4. PubMed ID: 19660366
    [No Abstract]   [Full Text] [Related]  

  • 18. Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale.
    Lopes RD; Alexander JH; Al-Khatib SM; Ansell J; Diaz R; Easton JD; Gersh BJ; Granger CB; Hanna M; Horowitz J; Hylek EM; McMurray JJ; Verheugt FW; Wallentin L;
    Am Heart J; 2010 Mar; 159(3):331-9. PubMed ID: 20211292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of apixaban compared to warfarin in the management of atrial fibrillation in Australia.
    Ademi Z; Pasupathi K; Liew D
    Eur J Prev Cardiol; 2015 Mar; 22(3):344-53. PubMed ID: 24281250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet Therapy and Adverse Hematologic Events During Heart Mate II Support.
    Saeed O; Shah A; Kargoli F; Madan S; Levin AP; Patel SR; Jermyn R; Guerrero C; Nguyen J; Sims DB; Shin J; D'Alessandro D; Goldstein DJ; Jorde UP
    Circ Heart Fail; 2016 Jan; 9(1):e002296. PubMed ID: 26721914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.